Keywords: BEMER therapy, blood indicators, wellness, exercise endurance, case study. Instytut Kultury Fizycznej, WydziaÅ‚ Kultury Fizycznej, Zdrowia i Turystyki, Uniwersytet Kazimierza Wielkiego, Bydgoszcz, Polska   SÅ‚owa kluczowe: terapia BEMER, wskaźniki krwi, odnowa biologiczna, wysiÅ‚ek wytrzymaÅ‚oÅ›ciowy, studium przypadku. Studium przypadku = Effect of BEMER therapy on selected indicators of blood in the process of wellness after exercise endurance. WpÅ‚yw terapii BEMER na wybrane wskaźniki krwi w ramach procesu odnowy biologicznej po wysiÅ‚ku wytrzymaÅ‚oÅ›ciowym. Such a combination may be especially useful for heavily treated patients suffering from advanced tumor and requiring additional aggressive chemotherapy which, however, at that time could represent almost life-threatening way of medication. A significant synergizing antitumor effect was seen when EL4 tumor-bearing mice were simultaneously exposed to EMF- BEMER and treated with suboptimal dose of synthetic HPMA copolymer-based doxorubicin, DOX(HYD)-HPMA. before solid tumor appeared, at the time of its aggressive growth, and at the terminal stage of the disease. No measurable levels of Hsp 70 or increased levels of specific anti-EL4 antibodies were detected in the serum taken from experimental mice before and at different intervals during the experiment, i.e. Acceleration of tumor growth was never observed. The effect was more pronounced in immuno-compromised nude mice compared to conventional ones. Exposure to EMF- BEMER slowed down the growth of tumor mass and prolonged the survival of experimental animals. We have investigated the effects of low-frequency pulsed electromagnetic field (LF-EMF) produced by BEMER device on experimental mouse T-cell lymphoma EL4 growing on conventional and/or athymic (nude) mice. ŘÃhová, Blanka Etrych, Tomáš Å Ãrová, Milada Tomala, Jakub Ulbrich, Karel Kovář, Marek Synergistic effect of EMF- BEMER-type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma. Further studies are necessary to better understand the mechanisms underlying the cellular alterations induced by the BEMER EMF pattern and to clarify the application areas for human disease. Intriguingly, exposure of cells to the BEMER EMF pattern failed to result in sensitization to chemotherapy and Cetuximab. Using more physiological, three-dimensional, matrix-based cell culture models and cancer cell lines originating from lung, head and neck, colorectal and pancreas, we show significant changes in distinct intermediates of the glycolysis and tricarboxylic acid cycle pathways and enhanced cancer cell radiosensitization associated with increased DNA double strand break numbers and higher levels of reactive oxygen species upon BEMER treatment relative to controls. Open remains whether this EMF pattern impacts on cancer cell survival upon treatment with radiotherapy, chemotherapy and the molecular-targeted agent Cetuximab inhibiting the epidermal growth factor receptor. A particular system is the BEMER therapy as a Physical Vascular Therapy for which a normalization of the microcirculation has been demonstrated by a low-frequency, pulsed EMF pattern. One investigated approach is the application of low-dose electromagnetic fields (EMF to modulate cellular processes. Particularly the latter is underpinned by the increasing utilization of non-invasive complementary and alternative medicine by the population. Owing to intrinsic and acquired resistance to these therapeutic approaches, both the better molecular understanding of tumor biology and the consideration of alternative and complementary therapeutic support are warranted and open up broader and novel possibilities for therapy personalization. On top, molecular-targeted agents are increasingly administered. If not, moving on.BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage.ĭirectory of Open Access Journals (Sweden)įull Text Available Each year more than 450,000 Germans are expected to be diagnosed with cancer subsequently receiving standard multimodal therapies including surgery, chemotherapy and radiotherapy. The future of the car is up in the air but many have read what I have planned if everything works out. Since then I have done a lot of things, many have come and gone. 2007 after trading my 2007 Cobalt LS(Pics provided of this) in for it after a test drive. Beamer | 2007 Cobalt SS/SC | Charlotte, NC (Sold)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |